Human milk IgA promotes normal immune development by limiting Th17-inducing Erysipelatoclostridium ramosum in the infant gut
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2501030122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Katherine Donald und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of British Columbia, Vancouver V6T 1Z3, BC, Canada. Hauptthemen laut MEDLINE: Milk, Human, Gastrointestinal Microbiome, Immunoglobulin A, Secretory, Th17 Cells. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The gut microbiota is highly dynamic during the first year of life and plays a crucial role in immune development. Breastfeeding is known to support infant health, but the contributions of the numerous breastmilk components to gut microbiota and immune maturation remain unclear. Secretory IgA (SIgA), the most abundant antibody in human milk, is a key modulator of gut microbiota composition. We have shown previously that mouse milk SIgA protects against asthma by limiting segmented filamentous bacteria in mice. The present study uncovers a similar mechanism in humans. Using human milk from the CHILD Cohort Study, we define a relationship between human milk SIgA and infant gut microbiota composition. This leads to the identification of Erysipelatoclostridium ramosum as a key player in immune development, which is controlled by milk SIgA. Cell culture modeling demonstrates that SIgA restricts the capacity of E. ramosum to adhere to the intestinal epithelium and to induce Th17 responses, which are implicated in allergic and other chronic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of British Columbia, Vancouver V6T 1Z3, BC, Canada.
- Michael Smith Laboratories, University of British Columbia, Vancouver V6T 1Z4, BC, Canada.
- Department of Microbiology and Molecular Genetics, University of California, Davis, CA 95616.
- Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver V6H 3N1, BC, Canada.
- Department of Pediatrics, University of Alberta, Edmonton T6G 1C9, AB, Canada.
- Faculty of Medicine and Health Sciences, University College Sedaya International University, Kuala Lumpur 71010, Malaysia.
ORCID-Profile: Tahereh Bozorgmehr, Mandi Ma, Theo J Moraes, Stuart Turvey, Meghan B Azad, B Brett Finlay
Zitieren
APA
Donald, K., Serapio-Palacios, A., Bozorgmehr, T., Ma, M., Garcia, M. A. I., Petersen, C., Mandhane, P., Subbarao, P., Moraes, T. J., Simons, E., Turvey, S., Azad, M. B., & Finlay, B. B. (2025). Human milk IgA promotes normal immune development by limiting Th17-inducing Erysipelatoclostridium ramosum in the infant gut. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2501030122
Vancouver
Donald K, Serapio-Palacios A, Bozorgmehr T, Ma M, Garcia MAI, Petersen C, et al. Human milk IgA promotes normal immune development by limiting Th17-inducing Erysipelatoclostridium ramosum in the infant gut. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2501030122
BibTeX
@article{Donald2025,
author = {Donald, Katherine and Serapio-Palacios, Antonio and Bozorgmehr, Tahereh and Ma, Mandi and Garcia, Ma Andrea Isabelle and Petersen, Charisse and Mandhane, Piushkumar and Subbarao, Padmaja and Moraes, Theo J and Simons, Elinor and Turvey, Stuart and Azad, Meghan B and Finlay, B Brett},
title = {Human milk IgA promotes normal immune development by limiting Th17-inducing Erysipelatoclostridium ramosum in the infant gut},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2501030122}
}
EUVIMED